Valuation (67%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 10.15 | N/A |
| PEG Ratio (TTM) | -0.29 | N/A |
| P/S Ratio (TTM) | 2.23 | N/A |
| P/B Ratio (TTM) | 0.61 | N/A |
| P/FCF Ratio (TTM) | 109.63 | N/A |
| Price to 5YR AVG Earnings Ratio | 1.32 | N/A |
| Price to 5YR AVG FCF Ratio | 1.42 | N/A |
Profitability (60%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 5.05% | N/A |
| ROE (TTM) | 5.80% | N/A |
| Net Profit Margin (TTM) | 21.18% | N/A |
| ROIC 5YR AVG | 25.63% | N/A |
Growth (43%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | -43.11% | 4.59% | 2.21% |
| Revenue | -1.58% | 15.77% | 5.16% |
| Net Income | -8.97% | 8.64% | 5.31% |
| Cash Flow | -16.33% | 26.02% | 25.59% |
Health (51%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 4.43 | N/A |
| Quick Ratio (TTM) | 4.43 | N/A |
| D/E Ratio (TTM) | N/A | N/A |
| Interest Coverage (TTM) | N/A | N/A |
| Piotroski F-Score | 7 | N/A |
| Altman Z-Score | 1.25 | N/A |
| LTL to 5YR AVG FCF | 0.13 | N/A |
| Shares Outstanding Growth 5YR AVG | 3.50% | N/A |